Search Results - "KAWANO, Kouichiro"

CD4/CD8 ratio is a prognostic factor in IgG nonresponders among peptide vaccine‐treated ovarian cancer patients by Waki, Kayoko, Kawano, Kouichiro, Tsuda, Naotake, Komatsu, Nobukazu, Yamada, Akira

“…The identification of useful biomarkers is an urgent issue in cancer treatment, particularly for immunotherapy, as only some patients experience benefits from…”
Get full text

Human papillomavirus genotyping predicts residual/recurrent disease after local treatment for cervical intraepithelial neoplasia better than viral DNA testing by Kawano, Kouichiro, Tsuda, Naotake, Nasu, Hiroki, Tasaki, Shingo, Park, Jongmyung, Tasaki, Kazuto, Terada, Atsumu, Nishio, Shin, Ushijima, Kimio

“…Aim Type‐specific persistent infection (TSPI) of human papillomavirus (HPV) is reportedly associated with a high risk of residual/recurrent disease after local…”
Get full text

Personalized peptide vaccination for cervical cancer patients who have received prior platinum‐based chemotherapy by Kawano, Kouichiro, Tsuda, Naotake, Waki, Kayoko, Matsueda, Satoko, Hata, Yoshiro, Ushijima, Kimio, Itoh, Kyogo, Yamada, Akira, Kamura, Toshiharu

“…A feasibility study was performed to evaluate the immunological efficacy and safety of a personalized peptide vaccine (PPV) for cervical cancer patients who…”
Get full text

Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients by Suekane, Shigetaka, Yutani, Shigeru, Yamada, Akira, Sasada, Tetsuro, Matsueda, Satoko, Takamori, Shinzo, Toh, Uhi, Kawano, Kouichiro, Yoshiyama, Koichi, Sakamoto, Shinjiro, Sugawara, Shunichi, Komatsu, Nobukazu, Yamada, Teppei, Naito, Masayasu, Terasaki, Mizuhiko, Mine, Takashi, Itoh, Kyogo, Shichijo, Shigeki, Noguchi, Masanori

“…Peptide‑based cancer vaccines have failed to provide sufficient clinical benefits in order to be approved in clinical trials since the 1990s. To understand the…”
Get full text

Plasma Levels of High-Mobility Group Box 1 during Peptide Vaccination in Patients with Recurrent Ovarian Cancer by Itoh, Kyogo, Ushijima, Kimio, Tsuda, Naotake, Kawano, Kouichiro, Waki, Kayoko, Yamada, Akira

“…High-mobility group box 1 (HMGB1) is a nuclear protein that is known to be secreted into extracellular fluids from injured cells, activated macrophages, and…”
Get full text

Comprehensive Molecular Profiling and Clinicopathological Characteristics of Gastric-Type Mucinous Carcinoma of the Uterine Cervix in Japanese Women by Nasu, Hiroki, Nishio, Shin, Park, Jongmyung, Tasaki, Kazuto, Terada, Atsumu, Tsuda, Naotake, Kawano, Kouichiro, Kojiro-Sanada, Sakiko, Akiba, Jun, Ushijima, Kimio

“…Gastric-type mucinous carcinoma (GAS) of the uterine cervix is the most common adenocarcinoma that develops independently of human papillomavirus infection; it…”
Get more information

Immunological evaluation of peptide vaccination for cancer patients with the HLA ‐A11+ or ‐A33+ allele by Sakamoto, Shinjiro, Matsueda, Satoko, Takamori, Shinzo, Toh, Uhi, Noguchi, Masanori, Yutani, Shigeru, Yamada, Akira, Shichijo, Shigeki, Yamada, Teppei, Suekane, Shigetaka, Kawano, Kouichiro, Naitou, Masayasu, Sasada, Tetsuro, Hattori, Noboru, Kohno, Nobuoki, Itoh, Kyogo

“…The HLA‐A11 or ‐A33 allele is found in approximately 18% or 10% of the Asian population, respectively, but each of which is a minor allele worldwide, and…”
Get full text

Identification of appropriate cone length to avoid positive cone margin in high grade cervical intraepithelial neoplasia by Kawano, Kouichiro, Tsuda, Naotake, Nishio, Shin, Yonemoto, Koji, Tasaki, Kazuto, Tasaki, Rurika, Ushijima, Kimio

“…To identify key factors for predicting positive cone margin and appropriate cone length. We retrospectively reviewed the margin status of patients who received…”
Get full text

Achievement of Surgical Proficiency in Laparoscopic Surgery for Early Endometrial Cancer by Gynecologic Oncologists by Kawano, Kouichiro, Tsuda, Naotake, Terada, Atsumu, Park, Jungmyung, Nasu, Hiroki, Matsukuma, Ken, Nishio, Shin, Ushijima, Kimio

“…Although studies have evaluated learning curves for laparoscopic surgery (LS), this issue has not yet been addressed in gynecologic oncologists. The present…”
Get more information

Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma by Nishio, Shin, Ushijima, Kimio, Tsuda, Naotake, Takemoto, Shuji, Kawano, Kouichiro, Yamaguchi, Tomohiko, Nishida, Naoyo, Kakuma, Tatsuyuki, Tsuda, Hitoshi, Kasamatsu, Takahiro, Sasajima, Yuko, Kage, Masayoshi, Kuwano, Michihiko, Kamura, Toshiharu

“…Abstract Cap43 is a nickel- and calcium-inducible gene that plays important roles in the primary growth of malignant tumors, as well as in invasion and…”
Get full text

Immunological evaluation of peptide vaccination for cancer patients with the HLA‐A26 allele by Sakamoto, Shinjiro, Matsueda, Satoko, Takamori, Shinzo, Toh, Uhi, Noguchi, Masanori, Yutani, Shigeru, Yamada, Akira, Shichijo, Shigeki, Yamada, Teppei, Suekane, Shigetaka, Kawano, Kouichiro, Sasada, Tetsuro, Hattori, Noboru, Kohno, Nobuoki, Itoh, Kyogo

“…To develop a peptide vaccine for cancer patients with the HLA‐A26 allele, which is a minor population worldwide, we investigated the immunological responses of…”
Get full text

Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device by Tsuda, Naotake, Ushijima, Kimio, Kawano, Kouichiro, Takemoto, Shuji, Nishio, Shin, Sonoda, Gounosuke, Kamura, Toshiharu

“…A number of new techniques have been developed to prevent lymphocele formation after pelvic lymphadenectomy in gynecologic cancers. We assessed whether the…”
Get full text

Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination by Noguchi, Masanori, Mine, Takashi, Komatsu, Nobukazu, Suekane, Shigetaka, Moriya, Fukuko, Matsuoka, Kei, Yutani, Shigeru, Shichijo, Shigeki, Yamada, Akira, Toh, Uhi, Kawano, Kouichiro, Azuma, Kouichi, Uemura, Hirotsugu, Okuno, Kiyotaka, Matsumoto, Kazumasa, Yanagimoto, Hiroaki, Yamanaka, Ryuya, Oka, Masaaki, Todo, Satoru, Sasada, Tetsuro, Itoh, Kyogo

“…To investigate immunological biomarkers to predict overall survival of advanced cancer patients under treatment with personalized peptide vaccination,…”
Get full text

Feasibility study of personalized peptide vaccination for recurrent ovarian cancer patients by Kawano, Kouichiro, Tsuda, Naotake, Matsueda, Satoko, Sasada, Tetsuro, Watanabe, Noriko, Ushijima, Kimio, Yamaguchi, Tomohiko, Yokomine, Masato, Itoh, Kyogo, Yamada, Akira, Kamura, Toshiharu

“…Abstract Context: To develop a personalized peptide vaccine (PPV) for recurrent ovarian cancer patients and evaluate its efficacy from the point of view of…”
Get full text

Identification of B cell epitopes reactive to human papillomavirus type-16L1- derived peptides by Fukui, Akimasa, Matsueda, Satoko, Kawano, Kouichiro, Tsuda, Naotake, Komatsu, Nobukazu, Shichijo, Shigeki, Sasada, Tetsuro, Hattori, Satoshi, Ushijima, Kimio, Itoh, Kyogo, Kamura, Toshiharu

“…Persistent infection of human papillomavirus (HPV) types 16 and 18 causes cervical cancer. To better understand immune responses to the prophylactic vaccine,…”
Get full text

Monitoring the impact of a national HPV vaccination program in Japan (MINT Study): rationale, design and methods by Matsumoto, Koji, Yaegashi, Nobuo, Iwata, Takashi, Ariyoshi, Kazuya, Fujiwara, Kiyoshi, Shiroyama, Yuko, Usami, Tomoka, Kawano, Yoshiaki, Horie, Koji, Kawano, Kouichiro, Noda, Kiichiro, Yoshikawa, Hiroyuki

“…We have developed a collaborative hospital-based approach to monitoring the impact of a human papillomavirus vaccine on cervical cancer, its precursor lesions…”
Get full text

Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG-G1402) by Hirakawa, Tomoko, Minaguchi, Takeo, Itani, Yoshio, Kasamatsu, Yuka, Murase, Saki, Sakurada, Shoko, Nagano, Hiroaki, Takehara, Kazuhiro, Tsuruta, Tomohiko, Arakawa, Atsushi, Kawano, Kouichiro, Tsubamoto, Hiroshi, Ushiwaka, Takashi, Mori, Taisuke, Iwai, Kana, Saito, Motoaki, Morisawa, Hiroyuki, Saito, Fumitaka, Yoshida, Kenta, Kaneuchi, Masanori, Sato, Hiroki, Ito, Kimihiko, Nasu, Kaei

“…This study aimed to evaluate the current status of secondary debulking surgery (SDS) and tertiary debulking surgery (TDS; performed for recurrence after SDS)…”
Get full text

Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study by Ushijima, Kimio, Fujiyoshi, Keizo, Kawano, Kouichiro, Tsuda, Naotake, Nishio, Shin, Eto, Hidehiro, Kamura, Toshiharu

“…To evaluate the clinical efficacy of concurrent chemoradiotherapy (CCRT) using daily low-dose cisplatin for cervical cancer. Fifty-one patients with locally…”
Get full text

Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary by Nishio, Shin, Ushijima, Kimio, Fukui, Akimasa, Fujiyoshi, Naoki, Kawano, Kouichiro, Komai, Kan, Ota, Shunichiro, Fujiyoshi, Keizo, Kamura, Toshiharu

“…Aim:  The aim of this study was to investigate whether fertility preservation influences the clinical outcome in patients with malignant germ cell tumors of…”
Get full text

Peptide YY producing strumal carcinoid of the ovary as the cause of severe constipation with contralateral epithelial ovarian cancer by Kawano, Kouichiro, Ushijima, Kimio, Fujimoto, Takefumi, Komai, Kan, Kamura, Toshiharu

“…Primary ovarian carcinoid tumors are rare. It has been reported that constipation was a presenting symptom in some patients with ovarian carcinoid. A case of…”
Get full text